Found 1 articles for: "Tildrakizumab Palmoplantar Pustulosis"

Successful Use of Tildrakizumab for Treatment of Palmoplantar Pustulosis: A Case Report

October 2021 | Volume 20 | Issue 10 | Case Reports | 1117 | Copyright © October 2021

Palmoplantar pustulosis (PPP) is a rare, recurrent skin disorder that presents a major challenge to clinical therapy. We report a case of a 69-year-old woman with a 20-year history of psoriasis with s...
Read More